Exact Mass: 273.0612746
Exact Mass Matches: 273.0612746
Found 97 metabolites which its exact mass value is equals to given mass value 273.0612746,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
ADEFOVIR
C8H12N5O4P (273.06268819999997)
A member of the class of phosphonic acids that is methylphosphonic acid in which one of the methyl hydrogens has been replaced by a 2-(6-amino-9H-purin-9-yl)ethoxy group. An inhibitor of HIV-1 reverse transcriptase, the bis(t-butoxycarbonyloxymethyl) ester (dipivoxil ester) prodrug is used to treat chronic hepatitis B viral infection. C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors C254 - Anti-Infective Agent > C281 - Antiviral Agent Same as: D02768
Carprofen
Carprofen is a non-steroidal anti-inflammatory drug (NSAID) that is used by veterinarians as a supportive treatment for the relief of arthritic symptoms in geriatric dogs. Carprofen was previously used in human medicine for over 10 years (1985-1995). It was generally well tolerated, with the majority of adverse effects being mild, such as gastro-intestinal pain and nausea, similar to those recorded with aspirin and other non-steroidal anti-inflammatory drugs. It is no longer marketed for human usage, after being withdrawn on commercial grounds. [Wikipedia] C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents Carprofen is a nonsteroid anti-inflammatory agent, acts as a multi-target FAAH/COX inhibitor, with IC50s of 3.9 μM, 22.3 μM and 78.6 μM for COX-2, COX-1 and FAAH, respectively.
Tolcapone
Tolcapone is a drug that inhibits the enzyme catechol-O-methyl transferase (COMT). It is used in the treatment of Parkinsons disease as an adjunct to levodopa/carbidopa medication. It is a yellow, odorless, non-hygroscopic, crystalline compound. Tolcapone is associated with a risk of hepatotoxicity. [Wikipedia] D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent
Ketamine hydrochloride
C13H17Cl2NO (273.06871320000005)
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics
Nebicapone
C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent C471 - Enzyme Inhibitor
(3R),5-dihydroxy-(4S)-methyl-3,4-dihydro-2,9,10-(2H)-1-azaanthracenetrione|laoticuzanone A
Tolcapone
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D065098 - Catechol O-Methyltransferase Inhibitors N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4727; ORIGINAL_PRECURSOR_SCAN_NO 4722 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4810; ORIGINAL_PRECURSOR_SCAN_NO 4806 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4841; ORIGINAL_PRECURSOR_SCAN_NO 4839 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4812; ORIGINAL_PRECURSOR_SCAN_NO 4809 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4900; ORIGINAL_PRECURSOR_SCAN_NO 4896 CONFIDENCE standard compound; INTERNAL_ID 273; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4752; ORIGINAL_PRECURSOR_SCAN_NO 4748
2-Methoxy-3-nitro-[1,1-biphenyl]-3-carboxylic acid
Ethanone,1-(2,4-dihydroxyphenyl)-2-(4-nitrophenyl)-
2-(4-Amino-2-Methyl-phenyl)-1,1,1,3,3,3-hexafluoro-propan-2-ol
C10H9F6NO (273.05882959999997)
6-fluoro-4-(trifluoromethyl)quinoline-2-carbohydrazide
2-[2-(2-amino-4-thiazolyl)ethyl]-1H-Isoindole-1,3(2H)-dione
3-[5-(2-METHYL-4-NITRO-PHENYL)-FURAN-2-YL]-ACRYLIC ACID
4-(Aminomethyl)-4-(3,4-dichlorophenyl)cyclohexanol
C13H17Cl2NO (273.06871320000005)
1,1,1,3,3,3-HEXAFLUORO-2-(4-(METHYLAMINO)PHENYL)PROPAN-2-OL
C10H9F6NO (273.05882959999997)
6,7-Dimethoxy-4-(trifluoromethyl)quinolin-2(1H)-one
esketamine hydrochloride
C13H17Cl2NO (273.06871320000005)
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
4-(aminomethyl)-4-(3,4-dichlorophenyl)cyclohexan-1-ol
C13H17Cl2NO (273.06871320000005)
2-(4-methoxy-N-methylsulfonylanilino)propanoic acid
4-[(Cyclopropylcarbonyl)amino]-2-(trifluoromethyl)benzoic acid
2-(4-AMINO-3-METHYLPHENYL)HEXAFLUOROISOPROPANOL
C10H9F6NO (273.05882959999997)
2-(2-Amino-4-Methyl-phenyl)-1,1,1,3,3,3-hexafluoro-propan-2-ol
C10H9F6NO (273.05882959999997)
(4-boronophenyl)methyl-trimethylazanium,bromide
C10H17BBrNO2 (273.05356320000004)
2-(tert-Butylamino)-3,4-chloropropiophenone hydrochloride
C13H17Cl2NO (273.06871320000005)
4-(6-Chloro-2-Methylsulfanyl-pyriMidin-4-ylaMino)-cyclohexanol
[1-(2,6-Dichloro-benzyl)-piperidin-2-yl]-methanol
C13H17Cl2NO (273.06871320000005)
2-(2-amino-5-methyl-phenyl)-1,1,1,3,3,3-hexafluoro-propan-2-ol
C10H9F6NO (273.05882959999997)
{[5-(CYCLOHEXYLAMINO)-1,3,4-THIADIAZOL-2-YL]THIO}ACETIC ACID
2-(2,5-Dimethylphenyl)-6-fluoro-1,2-benzothiazol-3-one
(R)-Carprofen
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
N4-(1,1-dioxo-3-thiolanyl)-5-nitropyrimidine-4,6-diamine
2-[(4-Chloro-2-methylphenoxy)methyl]imidazo[1,2-a]pyrimidine
3-(4-chlorophenyl)-2,5-dimethyl-1H-pyrazolo[1,5-a]pyrimidin-7-one
2-(4-Chlorophenoxy)-4-(dimethylamino)-3-pyridinecarbonitrile
2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide
Ketalar
C13H17Cl2NO (273.06871320000005)
D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics
(4-Amino-3-ethyl-2-sulfanylidene-5-thiazolyl)-(4-morpholinyl)methanone
N-[(3-methyl-6-imidazo[2,1-b]thiazolyl)methyl]-1-propanesulfonamide
2-(2,4-Dimethylphenyl)-6-fluoro-1,2-benzothiazol-3-one
5-ethyl-3-(5-oxo-2-sulfanylidene-4-imidazolidinylidene)-1H-indol-2-one
2-(4-chlorophenyl)-N-[(E)-pyridin-4-ylmethylideneamino]acetamide
carprofen
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D003879 - Dermatologic Agents Carprofen is a nonsteroid anti-inflammatory agent, acts as a multi-target FAAH/COX inhibitor, with IC50s of 3.9 μM, 22.3 μM and 78.6 μM for COX-2, COX-1 and FAAH, respectively.
8,10-dimethoxy-4,12,14-trioxa-2-azatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(16),2,5,7,9,11(15)-hexaene
4-hydroxy-2-{[hydroxy(2-hydroxyphenyl)methylidene]amino}benzoic acid
16-methoxy-2-methyl-4,12,14-trioxa-2-azatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1(16),3(7),5,9,11(15)-pentaen-8-one
2-benzamidobenzoic acid; 2',4-dihydroxy
{"Ingredient_id": "HBIN005343","Ingredient_name": "2-benzamidobenzoic acid; 2',4-dihydroxy","Alias": "NA","Ingredient_formula": "C14H11NO5","Ingredient_Smile": "NA","Ingredient_weight": "273.24","OB_score": "NA","CAS_id": "115610-40-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8694","PubChem_id": "NA","DrugBank_id": "NA"}